Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

CareFusion 213, LLC

US Class II Ongoing · initiated 2026-05-28

Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.

Ajanta Pharma USA Inc

US Class II Ongoing · initiated 2026-05-28

CGMP Deviations

CareFusion 213, LLC

US Class II Ongoing · initiated 2026-05-28

Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.

CareFusion 213, LLC

US Class I Ongoing · initiated 2026-05-28

Non-Sterility: Due to presence of Aspergillus penicillioides.

CareFusion 213, LLC

US Class I Ongoing · initiated 2026-05-28

Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal…

Lannett Company Inc.

US Class II Ongoing · initiated 2026-05-27

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

Ajanta Pharma USA Inc

US Class II Ongoing · initiated 2026-05-27

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.